Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval

Publisher Website
Google Scholar
Abstract
We studied effects of bretylium tosylate (6 mg·kg−1, injected intravenously over 60 s) on ventricular refractoriness and its inhomogeneity, and ventricular fibrillation threshold (VFT) in canine hearts with quinidine-induced long QT interval. In 13 anaesthetised open chest dogs, 30 mg·kg−1 of quinidine sulphate was injected intravenously over 5 min to produce QT prolongation. Effective refractory period (ERP) was determined at 8 test points of the right ventricle using extrastimuli. Temporal dispersion as an expression of inhomogeneity of ventricular refractoriness was estimated as the difference between the longest and the shortest ERP. VFT was determined using a train of pulses, 4 ms in duration and at 10 ms intervals. Effects of bretylium were determined from 30 to 60 min after injection. Quinidine-induced long QT interval did not change after bretylium (358 ± 37 vs 348 ± 26 ms) when transiently elevated blood pressure returned to the pre-bretylium level. Bretylium shortened ERP slightly (278 ± 16 vs 268 ± 14 ms, p<0.02) but did not shorten ERP after premature depolarisation (209 ± 14 vs 209 ± 15). However, temporal dispersion was significantly decreased by bretylium. VFT, which was lowered by quinidine (14.5 ± 5.0 vs 8.5 ± 2.9 mA, p<0.01), was elevated significantly by bretylium (21.9 ± 6.9, p<0.001). These effects of bretylium might be attributed to the combination of its direct electrophysiological and indirect adrenergic actions.